Prevention and treatment of cytomegalovirus disease in thoracic organ transplant patients: evidence for a beneficial effect of hyperimmune globulin.
D003362:Cost-Benefit Analysis; D003587:Cytomegalovirus / Q000302:isolation & purification; D003586:Cytomegalovirus Infections / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control*; D016027:Heart Transplantation; D016041:Heart-Lung Transplantation; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000191:economics / Q000627:therapeutic use*; D016040:Lung Transplantation; D016133:Polymerase Chain Reaction / Q000379:methods; D011183:Postoperative Complications / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control
D016756:Immunoglobulins, Intravenous